Elekta (OTCMKTS:EKTAY) Shares Down 13.2% – What’s Next?

Elekta AB (OTCMKTS:EKTAY) shares fell 13.2% on Friday . The company traded as low as $5.7530 and last traded at $5.7530. 267 shares traded hands during mid-day trading, a decline of 89% from the average session volume of 2,419 shares. The stock had previously closed at $6.63.

Elekta Trading Down 13.2%

The firm has a market capitalization of $2.12 billion, a PE ratio of -574.73 and a beta of 1.01. The business has a 50 day moving average price of $6.01 and a 200-day moving average price of $5.99. The company has a current ratio of 0.95, a quick ratio of 0.73 and a debt-to-equity ratio of 0.56.

Elekta (OTCMKTS:EKTAY) last posted its quarterly earnings results on Thursday, May 28th. The company reported $0.06 earnings per share for the quarter. The firm had revenue of $521.00 million for the quarter. Elekta had a positive return on equity of 12.84% and a negative net margin of 0.08%. Analysts expect that Elekta AB will post 0.39 earnings per share for the current year.

About Elekta

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.